Evidence map›Paper›PMID 23381943›Full record

SynthesisAnnals of neurology2013

Ischemic stroke is associated with the ABO locus: the EuroCLOT study.

Frances M K Williams, Angela M Carter, Pirro G Hysi, Gabriela Surdulescu, Dylan Hodgkiss, Nicole Soranzo, Matthew Traylor, Steve Bevan, Martin Dichgans, Peter M W Rothwell and 53 more

Erratum issuedOpen access · bronzeAbstract readMeta-AnalysisTwin Study
In one paragraph

Synthesis in Annals of neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 100 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 7 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 7 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Pooled it
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Observational
  17. Epigenetics as a target to mitigate excess stroke risk in people of African ancestry: A scoping review.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2024
    Article
  18. Article
  19. Review
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

63 authors at 20 institutions in 10 countries.

Frances M K WilliamsDepartment of Twin Research and Genetic Epidemiology, King's College London, United Kingdom. frances.williams@kcl.ac.uk
Angela M Carter
Pirro G Hysi
Gabriela Surdulescu
Dylan Hodgkiss
Nicole Soranzo
Matthew Traylor
Steve Bevan
Martin Dichgans
Peter M W Rothwell
Cathie Sudlow
Martin Farrall
Kaisa Silander
Mari Kaunisto
Peter Wagner
Olli Saarela
Kari Kuulasmaa
Jarmo Virtamo
Veikko Salomaa
Philippe Amouyel
Dominique Arveiler
Jean Ferrieres
Per-Gunnar Wiklund
M Arfan Ikram
Albert Hofman
Giorgio B Boncoraglio
Eugenio A Parati
Anna Helgadottir
Solveig Gretarsdottir
Unnur Thorsteinsdottir
Gudmar Thorleifsson
Kari Stefansson
Sudha Seshadri
Anita DeStefano
Andreas Gschwendtner
Bruce Psaty
Will Longstreth
Braxton D Mitchell
Yu-Ching Cheng
Robert Clarke
Marco Ferrario
Joshua C Bis
Christopher Levi
John Attia
Elizabeth G Holliday
Rodney J Scott
Myriam Fornage
Pankaj Sharma
Karen L Furie
Jonathan Rosand
Mike Nalls
James Meschia
Thomas H Mosely
Alun Evans
Aarno Palotie
Hugh S Markus
Peter J Grant
Tim D Spector
EuroCLOT Investigators
Wellcome Trust Case Control Consortium 2
MOnica Risk, Genetics, Archiving and Monograph
MetaStroke
International Stroke Genetics Consortium
deCODE Genetics (Iceland) · ISKing's College London · GBFinnish Institute for Health and Welfare · FIJohn Hunter Hospital · AUUniversity of Oxford · GBSt George's, University of London · GBUniversity of Helsinki · FIBoston University · USBroad Institute · USErasmus MC · NLFondazione IRCCS Istituto Neurologico Carlo Besta · ITJackson Memorial Hospital · USUniversity of Leeds · GBWinnMed · USCentre for Human Genetics · GBDementia UK · GBGroup Health Cooperative · USHarvard University · USHôpital Purpan · FRImperial College London · GB

Funding

The Baltimore Longitudinal Study Of AgingZIAAG000015 · NIA · NATIONAL INSTITUTE ON AGING · PI SIMONSICK, ELEANOR MARIE · 2009 to 2025
$116.9M
Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D, TAYLOR, SIMEON I. · 2005 to 2019
$17.3M
UCLA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR033176 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2011 to 2011
$15.5M
EPIDEMIOLOGY OF DEMENTIA IN THE FRAMINGHAM STUDYR01AG008122 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, SESHADRI, SUDHA · 1989 to 2015
$14.4M
MRI, Genetics &Cognitive Precursors of AD &DementiaR01AG016495 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 1999 to 2016
$12.5M
Epidemiology of Venous Thrombosis & Pulmonary EmbolismR01HL059367 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI TANG, WEIHONG · 1998 to 2024
$11.8M
THE BALTIMORE LONGITUDINAL STUDY OF HUMAN AGINGZ01AG000015 · NIA · NATIONAL INSTITUTE ON AGING · PI FERRUCCI, LUIGI · 1985 to 2008
$11.4M
Department of HealthIntramural NIH HHS Z01 AG000015Intramural NIH HHS Z01 AG000954NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1RR025005NCRR NIH HHS UL1 RR033176NCRR NIH HHS UL 1RR033176NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004402NHGRI NIH HHS U01HG004402NHGRI NIH HHS U01 HG004436NHGRI NIH HHS U01 HG 004446NHGRI NIH HHS U01 HG004446NHLBI NIH HHS HHSN268201100005CNHLBI NIH HHS HHSN268201100005GNHLBI NIH HHS HHSN268201100005INHLBI NIH HHS HHSN268201100006CNHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007INHLBI NIH HHS HHSN268201100008CNHLBI NIH HHS HHSN268201100008INHLBI NIH HHS HHSN268201100009CNHLBI NIH HHS HHSN268201100009INHLBI NIH HHS HHSN268201100010CNHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100011INHLBI NIH HHS HHSN268201100012CNHLBI NIH HHS HL075366NHLBI NIH HHS HL080295NHLBI NIH HHS HL087652NHLBI NIH HHS HL093029NHLBI NIH HHS HL105756NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01 HC035129NHLBI NIH HHS N01 HC045133NHLBI NIH HHS N01 HC055222NHLBI NIH HHS N01 HC075150NHLBI NIH HHS N01 HC085079NHLBI NIH HHS N01 HC085080NHLBI NIH HHS N01 HC085081NHLBI NIH HHS N01 HC085082NHLBI NIH HHS N01 HC085083NHLBI NIH HHS N01 HC085084NHLBI NIH HHS N01 HC085085NHLBI NIH HHS N01 HC085086NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS N01 HC-55222NHLBI NIH HHS N01-HC-75150NHLBI NIH HHS N01-HC-85079NHLBI NIH HHS N01-HC-85080NHLBI NIH HHS N01-HC-85081NHLBI NIH HHS N01-HC-85082NHLBI NIH HHS N01-HC-85083NHLBI NIH HHS N01-HC-85086NHLBI NIH HHS N01-HC-85239NHLBI NIH HHS N02 HL064278NHLBI NIH HHS N02-HL-6-4278NHLBI NIH HHS R01 HL059367NHLBI NIH HHS R01 HL073410NHLBI NIH HHS R01 HL075366NHLBI NIH HHS R01 HL080295NHLBI NIH HHS R01 HL085251NHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01HL086694NHLBI NIH HHS R01 HL087641NHLBI NIH HHS R01HL087641NHLBI NIH HHS R01 HL087652NHLBI NIH HHS R01 HL093029NHLBI NIH HHS R01 HL105756NHLBI NIH HHS R01HL59367NHLBI NIH HHS U01 HL080295NIA NIH HHS AG-023629NIA NIH HHS AG-027058NIA NIH HHS AG031287NIA NIH HHS AG033193NIA NIH HHS AG08122NIA NIH HHS AG16495NIA NIH HHS AG-20098NIA NIH HHS P30 AG010129NIA NIH HHS R01 AG008122NIA NIH HHS R01 AG015928NIA NIH HHS R01 AG016495NIA NIH HHS R01 AG020098NIA NIH HHS R01 AG023629NIA NIH HHS R01 AG027058NIA NIH HHS R01 AG031287NIA NIH HHS R01 AG033193NIA NIH HHS R56 AG020098NIA NIH HHS R56 AG023629NIA NIH HHS Z01 AG-000015-50NIA NIH HHS Z01 AG-000954-06NIDDK NIH HHS DK063491NIDDK NIH HHS P30 DK063491NIDDK NIH HHS P30 DK072488NIDDK NIH HHS P30DK072488NINDS NIH HHS NS17950NINDS NIH HHS R01 NS017950NINDS NIH HHS R01 NS039987NINDS NIH HHS R01 NS042733NINDS NIH HHS R01 NS045012NINDS NIH HHS R01 NS-39987NINDS NIH HHS R01 NS-42733NINDS NIH HHS R01 NS45012NINDS NIH HHS U01 NS069208NINDS NIH HHS U01NS069208NINDS NIH HHS U01 NS069208-01PHS HHS HHSN268200625226CThe Dunhill Medical Trust OSRP2/1006Wellcome Trust 075491/Z/04Wellcome Trust 085475/B/08/ZWellcome Trust 085475/Z/08/ZWellcome Trust 090532Wellcome Trust 090532/Z09/ZWellcome Trust 095626Wellcome Trust 098051Wellcome Trust WT084724MAWellcome Trust WT091310Wellcome Trust WT098051
6 · The paper itself

Abstract

objectiveEnd-stage coagulation and the structure/function of fibrin are implicated in the pathogenesis of ischemic stroke. We explored whether genetic variants associated with end-stage coagulation in healthy volunteers account for the genetic predisposition to ischemic stroke and examined their influence on stroke subtype.

methodsCommon genetic variants identified through genome-wide association studies of coagulation factors and fibrin structure/function in healthy twins (n = 2,100, Stage 1) were examined in ischemic stroke (n = 4,200 cases) using 2 independent samples of European ancestry (Stage 2). A third clinical collection having stroke subtyping (total 8,900 cases, 55,000 controls) was used for replication (Stage 3).

resultsStage 1 identified 524 single nucleotide polymorphisms (SNPs) from 23 linkage disequilibrium blocks having significant association (p < 5 × 10(-8)) with 1 or more coagulation/fibrin phenotypes. The most striking associations included SNP rs5985 with factor XIII activity (p = 2.6 × 10(-186)), rs10665 with FVII (p = 2.4 × 10(-47)), and rs505922 in the ABO gene with both von Willebrand factor (p = 4.7 × 10(-57)) and factor VIII (p = 1.2 × 10(-36)). In Stage 2, the 23 independent SNPs were examined in stroke cases/noncases using MOnica Risk, Genetics, Archiving and Monograph (MORGAM) and Wellcome Trust Case Control Consortium 2 collections. SNP rs505922 was nominally associated with ischemic stroke (odds ratio = 0.94, 95% confidence interval = 0.88-0.99, p = 0.023). Independent replication in Meta-Stroke confirmed the rs505922 association with stroke, beta (standard error, SE) = 0.066 (0.02), p = 0.001, a finding specific to large-vessel and cardioembolic stroke (p = 0.001 and p = < 0.001, respectively) but not seen with small-vessel stroke (p = 0.811).

interpretationABO gene variants are associated with large-vessel and cardioembolic stroke but not small-vessel disease. This work sheds light on the different pathogenic mechanisms underpinning stroke subtype.

Indexed as

Genome-Wide Association StudyABO Blood-Group SystemAdolescentAdultAgedAged, 80 and overBlood CoagulationBrain IschemiaCohort StudiesEuropeFemaleGenetic LociGenetic Predisposition to DiseaseGenetic VariationHumansMaleABO Blood-Group System

Identifiers

PMID23381943
PMCPMC3582024
OpenAlexW2117419192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.